Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · May 22, 2024

Long-Term Outcomes After Treatment of Delirium During Critical Illness With Antipsychotics

The Lancet Respiratory Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Respiratory Medicine
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial
Lancet Respir Med 2024 Apr 30;[EPub Ahead of Print], MF Mart, LM Boehm, AL Kiehl, MN Gong, A Malhotra, RL Owens, BA Khan, MA Pisani, GA Schmidt, RD Hite, MC Exline, SS Carson, CL Hough, P Rock, IS Douglas, DJ Feinstein, RC Hyzy, WD Schweickert, DL Bowton, A Masica, OM Orun, R Raman, BT Pun, C Strength, ML Rolfsen, PP Pandharipande, NE Brummel, CG Hughes, MB Patel, JL Stollings, EW Ely, JC Jackson, TD Girard

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading